+44 (0)114 215 9667 mellanbycentre@sheffield.ac.uk


Dr Ingunn Holen

Brown H.K., Ottewell P.D., Evans C.A., Coleman R.E., Holen I. (2012) A single administration of combination therapy inhibits breast tumour progression in bone and modifies both osteoblast and osteoclasts. Journal of Bone Oncology 1:47-56.

Holen I., Whitworth J., Nutter F., Evans C.A., Brown H.K., Barbaric I., Jones M., Ottewell P.D. (2012) Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo. Breast Cancer Res May 25;14(3):R86

Brown H.K., Ottewell P.D., Evans C.A., Holen I. (2012) Location matters – osteoblast and osteoclast distribution is modified by the presence and proximity to breast cancer cells in vivo. Clinical and Experimental Metastasis May 6th

Wilson C., Holen I., Coleman R.E. (2012) Seed, soil and secreted hormones: Potential interactions of breast cancer cells with their endocrine/paracrine microenvironment and implications for treatment with bone targeted agents. Cancer Treat Rev 38(7):877-89.